Hyperthermia Treatment For Cancer Market
Global Hyperthermia Treatment for Cancer Market Size, Share & Trends Analysis Report by Application (Breast Cancer, Liver Cancer, Soft Tissue Sarcoma, Leukemia, Head and Neck Tumors, and Prostate Cancer), By Device Type (Microwave Hyperthermia Device, Ultrasound Hyperthermia Device, Infrared Hyperthermia Device, and Short-wave Hyperthermia Device), By End-User (Hospitals, Clinics, Research Institutes, and Cancer Centers), Forecast 2022-2028 Update Available - Forecast 2024-2030
The hyperthermia treatment for cancer market is expected to grow at a significant CAGR of around 5.9% during the forecast period. The major factor accelerating the growth of the market include rising prevalence of cancer globally, growing awareness regarding the therapeutic effect of hyperthermia on various cancers and significant advancements in hyperthermia treatment devices. According to World Health Organization (WHO), the number of deaths from cancer all over the world will reach around 13.1 million by 2030, and also data from WHO suggests that global cancer prevalence will increase by approximately 75% by 2030. The quickly growing rate of cancer will lead to an increased number of patients opting for cancer therapies which boosts the hyperthermia treatment market.
Apart from these, the new product launches by prominent players will further projected to drive the market growth. However, the high cost associated with hyperthermia treatment is the major factor that may hinder the market growth.
Impact of COVID-19 Pandemic on Hyperthermia Treatment for Cancer Market
The COVID-19 pandemic has impacted the global economy due to a slowdown in the manufacturing of various industries. Due to the COVID-19 outbreak investment in the healthcare market has increased and especially towards cancer patients, since these patients are at high risk of contracting the infection, owing to low immunity levels. As clinicians have boosted their capabilities in telemedicine and other digital platforms to increase accessibility to patient care, this has created revenue opportunities for companies in the hyperthermia cancer treatment market.
Segmental Outlook
Global hyperthermia treatment for cancer market is segmented based on application, device type, and end-user. Based on application, the market is sub-segmented into breast cancer, liver cancer, soft tissue sarcoma, leukemia, head and neck tumors, and prostate cancer. Based on the device type, the market is sub-segmented into microwave hyperthermia devices, ultrasound hyperthermia devices, infrared hyperthermia devices, and short-wave hyperthermia devices. Based on the end-user, the market is sub-segmented into hospitals, clinics, research institutes, and cancer centers. Among these, microwave hyperthermia devices dominated the global market, as the microwave technique enables heat treatment of tumors, which are deep-seated and relatively hard to access in the body, due to which the preference and adoption of this device is high among doctors for cancer treatments.
Global Hyperthermia Treatment For Cancer Market Share by Device Type, 2021 (%)
The Microwave Hyperthermia Device is Predicated to Hold Prominent Share in the Global Hyperthermia Treatment for Cancer Market
Based on device type, the microwave hyperthermia device held the significant share in the market in 2021, and it is further likely to hold the largest share in the market. The hyperthermia treatment for cancer with microwave hyperthermia device enables heat treatment of tumors which are deep-seated and/or relatively hard to access in the body. The microwaves are transmitted from a number of antennas enclosing the relevant body part. Moreover, microwave hyperthermia can be utilized as a complementary treatment technique to enhance the effectiveness of main treatment methods such as chemotherapy. Hence this drives their adoption in various cancer treatments. .
Regional Outlooks
Geographically, the global hyperthermia treatment for cancer market is further segmented on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). Asia-Pacific is estimated to grow at the fastest CAGR during the forecast period. The regional growth is attributed to the presence of a huge population base affected with cancer, high adoption of innovative products aiming at cancer treatment, and rising healthcare infrastructure spending by the government to make healthcare facilities more strong with the adoption of new devices and treatments for cancer.
Global Hyperthermia Treatment for Cancer Market Growth, by region 2022-2028
North America Region is Estimated to Hold the Major Share in the Global Hyperthermia Treatment for Cancer Market
North America is anticipated to hold a prominent share in the market mainly due to the increase in the incidence of cancer and significant product launches by prominent players in the market. According to the National Cancer Institute, 39.5% of patients will be diagnosed with cancer at some point in their lives. However, the number of survivors is likely to reach 22.2 million by 2030 due to hyperthermia treatment for cancer. Apart from these, the presence of medical device manufacturing companies, high awareness level among populations about different treatment options such as hyperthermia treatment for cancer is further leading to the market growth in the region.
Market Players Outlook
The major companies serving the global hyperthermia treatment for cancer market include Pyrexar Medical Inc., Hydrosun Medizintechnik GmbH, Celsius42 GmbH, Chongqing Haifu medical technology Co. Ltd., Yamamoto Vinita Co., Ltd., innoMedicus Ltd., and others. The growth of the market is considerably contributed by the market player for the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in Feb. 2021, innoMedicus Ltd. published a study in JAMA Oncology, establishing that non-contrast MRI yields a better diagnosis of prostate cancer.
The Report Covers
- Market value data analysis of 2022 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global Hyperthermia Treatment for Cancer Market. Based on the availability of data, information related to the market, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Impact of COVID-19 on The Global Hyperthermia Treatment for Cancer Market
- Recovery Scenario of Global Hyperthermia Treatment for Cancer Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Pyrexar Medical Inc.
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Hydrosun Medizintechnik GmbH
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Celsius42 GmbH
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Chongqing Haifu Medical Technology Co. Ltd.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Yamamoto Vinita Co., Ltd.
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Hyperthermia Treatment for Cancer Market by Application
4.1.1. Breast Cancer
4.1.2. Liver Cancer
4.1.3. Soft Tissue Sarcoma
4.1.4. Leukemia
4.1.5. Head and Neck Tumors
4.1.6. Prostate Cancer
4.2. Global Hyperthermia Treatment for Cancer Market by Device Type
4.2.1. Microwave Hyperthermia Device
4.2.2. Ultrasound Hyperthermia Device
4.2.3. Infrared Hyperthermia Device
4.2.4. Short-wave Hyperthermia Device
4.3. Global Hyperthermia Treatment for Cancer Market by End-User
4.3.1. Hospitals
4.3.2. Clinics
4.3.3. Research Institutes
4.3.4. Cancer Centers
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Andromedic S.r.l.
6.2. Gamida Cell Ltd.
6.3. Hyperthermia Cancer Institute
6.4. Heckle medizintechnik GmbH
6.5. ICHS
6.6. innoMedicus Ltd.
6.7. Oncotherm Kft.
6.8. Omron Corp.
6.9. RAND Corp.
1. GLOBAL HYPERTHERMIA TREATMENT FOR CANCER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
2. GLOBAL HYPERTHERMIA TREATMENT FOR BREAST CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL HYPERTHERMIA TREATMENT FOR LIVER CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL HYPERTHERMIA TREATMENT FOR SOFT TISSUE SARCOMA MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL HYPERTHERMIA TREATMENT FOR LEUKEMIA MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL HYPERTHERMIA TREATMENT FOR HEAD AND NECK TUMORS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL HYPERTHERMIA TREATMENT FOR PROSTATE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL HYPERTHERMIA TREATMENT FOR CANCER MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2021-2028 ($ MILLION)
9. GLOBAL MICROWAVE HYPERTHERMIA IN HYPERTHERMIA TREATMENT FOR CANCER MARKET MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL ULTRASOUND IN HYPERTHERMIA TREATMENT FOR CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL INFRARED IN HYPERTHERMIA TREATMENT FOR CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL SHORT-WAVE IN HYPERTHERMIA TREATMENT FOR CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBAL HYPERTHERMIA TREATMENT FOR CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
14. GLOBAL HYPERTHERMIA TREATMENT FOR CANCER IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
15. GLOBAL HYPERTHERMIA TREATMENT FOR CANCER IN CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
16. GLOBAL HYPERTHERMIA TREATMENT FOR CANCER IN RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
17. GLOBAL HYPERTHERMIA TREATMENT FOR CANCER IN CANCER CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
18. GLOBAL HYPERTHERMIA TREATMENT FOR CANCER MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
19. NORTH AMERICAN HYPERTHERMIA TREATMENT FOR CANCER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
20. NORTH AMERICAN HYPERTHERMIA TREATMENT FOR CANCER MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2021-2028 ($ MILLION)
21. NORTH AMERICAN HYPERTHERMIA TREATMENT FOR CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
22. EUROPEAN HYPERTHERMIA TREATMENT FOR CANCER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
23. EUROPEAN HYPERTHERMIA TREATMENT FOR CANCER MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2021-2028 ($ MILLION)
24. EUROPEAN HYPERTHERMIA TREATMENT FOR CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
25. ASIA-PACIFIC HYPERTHERMIA TREATMENT FOR CANCER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
26. ASIA-PACIFIC HYPERTHERMIA TREATMENT FOR CANCER MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2021-2028 ($ MILLION)
27. ASIA-PACIFIC HYPERTHERMIA TREATMENT FOR CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
28. REST OF THE WORLD HYPERTHERMIA TREATMENT FOR CANCER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
29. REST OF THE WORLD HYPERTHERMIA TREATMENT FOR CANCER MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2021-2028 ($ MILLION)
30. REST OF THE WORLD HYPERTHERMIA TREATMENT FOR CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL HYPERTHERMIA TREATMENT FOR CANCER MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL HYPERTHERMIA TREATMENT FOR CANCER MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL HYPERTHERMIA TREATMENT FOR CANCER MARKET, 2022-2028 (%)
4. GLOBAL HYPERTHERMIA TREATMENT FOR CANCER MARKET BY APPLICATION, 2021 VS 2028 (%)
5. GLOBAL HYPERTHERMIA TREATMENT FOR CANCER MARKET BY DEVICE TYPE, 2021 VS 2028 (%)
6. GLOBAL HYPERTHERMIA TREATMENT FOR CANCER MARKET BY END-USER, 2021 VS 2028 (%)
7. GLOBAL BREAST CANCER HYPERTHERMIA TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL LIVER CANCER HYPERTHERMIA TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL SOFT TISSUE SARCOMA HYPERTHERMIA TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL LEUKEMIA CANCER HYPERTHERMIA TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL HEAD AND NECK TUMORS HYPERTHERMIA TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL PROSTATE CANCER HYPERTHERMIA TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL HYPERTHERMIA TREATMENT FOR CANCER MARKET SHARE BY DEVICE TYPE, 2021 VS 2028 (%)
14. GLOBAL MICROWAVE DEVICE IN HYPERTHERMIA TREATMENT FOR CANCER MARKET, SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. GLOBAL ULTRASOUND DEVICE IN HYPERTHERMIA TREATMENT FOR CANCER MARKET, SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16. GLOBAL INFRARED DEVICE IN HYPERTHERMIA TREATMENT FOR CANCER MARKET, SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
17. GLOBAL SHORT-WAVE DEVICE IN HYPERTHERMIA TREATMENT FOR CANCER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
18. GLOBAL HYPERTHERMIA TREATMENT FOR CANCER MARKET SHARE BY END-USER, 2021 VS 2028 (%)
19. GLOBAL HYPERTHERMIA TREATMENT FOR CANCER IN HOSPITALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
20. GLOBAL HYPERTHERMIA TREATMENT FOR CANCER IN CLINICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
21. GLOBAL HYPERTHERMIA TREATMENT FOR CANCER IN RESEARCH INSTITUTES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
22. GLOBAL HYPERTHERMIA TREATMENT FOR CANCER IN CANCER CENTERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
23. GLOBAL HYPERTHERMIA TREATMENT FOR CANCER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
24. US HYPERTHERMIA TREATMENT FOR CANCER MARKET SIZE, 2021-2028 ($ MILLION)
25. CANADA HYPERTHERMIA TREATMENT FOR CANCER MARKET SIZE, 2021-2028 ($ MILLION)
26. UK HYPERTHERMIA TREATMENT FOR CANCER MARKET SIZE, 2021-2028 ($ MILLION)
27. FRANCE HYPERTHERMIA TREATMENT FOR CANCER MARKET SIZE, 2021-2028 ($ MILLION)
28. GERMANY HYPERTHERMIA TREATMENT FOR CANCER MARKET SIZE, 2021-2028 ($ MILLION)
29. ITALY HYPERTHERMIA TREATMENT FOR CANCER MARKET SIZE, 2021-2028 ($ MILLION)
30. SPAIN HYPERTHERMIA TREATMENT FOR CANCER MARKET SIZE, 2021-2028 ($ MILLION)
31. REST OF EUROPE HYPERTHERMIA TREATMENT FOR CANCER MARKET SIZE, 2021-2028 ($ MILLION)
32. INDIA HYPERTHERMIA TREATMENT FOR CANCER MARKET SIZE, 2021-2028 ($ MILLION)
33. CHINA HYPERTHERMIA TREATMENT FOR CANCER MARKET SIZE, 2021-2028 ($ MILLION)
34. JAPAN HYPERTHERMIA TREATMENT FOR CANCER MARKET SIZE, 2021-2028 ($ MILLION)
35. SOUTH KOREA HYPERTHERMIA TREATMENT FOR CANCER MARKET SIZE, 2021-2028 ($ MILLION)
36. REST OF ASIA-PACIFIC HYPERTHERMIA TREATMENT FOR CANCER MARKET SIZE, 2021-2028 ($ MILLION)
37. REST OF THE WORLD HYPERTHERMIA TREATMENT FOR CANCER MARKET SIZE, 2021-2028 ($ MILLION)
